Our study also demonstrated that the forced expression of PLK1 induces resistance to 5-Fu in CRC cell lines (Figure S2), while its pharmacological inhibition effectively reverses chemoresistance, restoring sensitivity to 5-Fu treatment. Here, PLK1 is linked to colorectal carcinoma.